Phibro Animal Health Corporation PB8.F Stock
Phibro Animal Health Corporation Price Chart
Phibro Animal Health Corporation PB8.F Financial and Trading Overview
Phibro Animal Health Corporation stock price | 12 EUR |
Previous Close | 12.4 EUR |
Open | 12.3 EUR |
Bid | 12.3 EUR x 20000 |
Ask | 12.7 EUR x 20000 |
Day's Range | 12.3 - 12.3 EUR |
52 Week Range | 11.5 - 19.5 EUR |
Volume | 48 EUR |
Avg. Volume | 0 EUR |
Market Cap | 500.25M EUR |
Beta (5Y Monthly) | 0.616549 |
PE Ratio (TTM) | 18.636364 |
EPS (TTM) | 0.34 EUR |
Forward Dividend & Yield | 0.45 (3.59%) |
Ex-Dividend Date | June 6, 2023 |
1y Target Est | 20 EUR |
PB8.F Valuation Measures
Enterprise Value | 938.59M EUR |
Trailing P/E | 18.636364 |
Forward P/E | 9.111111 |
PEG Ratio (5 yr expected) | 3.22 |
Price/Sales (ttm) | 0.51145023 |
Price/Book (mrq) | 1.8292683 |
Enterprise Value/Revenue | 0.96 |
Enterprise Value/EBITDA | 8.72 |
Trading Information
Phibro Animal Health Corporation Stock Price History
Beta (5Y Monthly) | 0.616549 |
52-Week Change | -24.55% |
S&P500 52-Week Change | 20.43% |
52 Week High | 19.5 EUR |
52 Week Low | 11.5 EUR |
50-Day Moving Average | 13.12 EUR |
200-Day Moving Average | 13.49 EUR |
PB8.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 4 EUR |
Shares Outstanding | 20.34M |
Float | 20.23M |
Short Ratio | N/A |
% Held by Insiders | 0.54% |
% Held by Institutions | 100.95% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.48 |
Trailing Annual Dividend Yield | 3.87% |
5 Year Average Dividend Yield | 218.00% |
Payout Ratio | 0.6857 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 2.92% |
Operating Margin (ttm) | 7.65% |
Gross Margin | 30.69% |
EBITDA Margin | 11.00% |
Management Effectiveness
Return on Assets (ttm) | 4.97% |
Return on Equity (ttm) | 10.60% |
Income Statement
Revenue (ttm) | 978.11M EUR |
Revenue Per Share (ttm) | 24.15 EUR |
Quarterly Revenue Growth (yoy) | 2.50% |
Gross Profit (ttm) | 285.72M EUR |
EBITDA | 107.64M EUR |
Net Income Avi to Common (ttm) | 28.6M EUR |
Diluted EPS (ttm) | 0.66 |
Quarterly Earnings Growth (yoy) | -43.20% |
Balance Sheet
Total Cash (mrq) | 89.47M EUR |
Total Cash Per Share (mrq) | 2.21 EUR |
Total Debt (mrq) | 517.71M EUR |
Total Debt/Equity (mrq) | 190.11 EUR |
Current Ratio (mrq) | 3.542 |
Book Value Per Share (mrq) | 6.724 |
Cash Flow Statement
Operating Cash Flow (ttm) | -5354000 EUR |
Levered Free Cash Flow (ttm) | -49361376 EUR |
Profile of Phibro Animal Health Corporation
Country | Germany |
State | NJ |
City | Teaneck |
Address | Glenpointe Centre East |
ZIP | 07666-6712 |
Phone | 201 329 7300 |
Website | https://www.pahc.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1860 |
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
Q&A For Phibro Animal Health Corporation Stock
What is a current PB8.F stock price?
Phibro Animal Health Corporation PB8.F stock price today per share is 12 EUR.
How to purchase Phibro Animal Health Corporation stock?
You can buy PB8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Phibro Animal Health Corporation?
The stock symbol or ticker of Phibro Animal Health Corporation is PB8.F.
Which industry does the Phibro Animal Health Corporation company belong to?
The Phibro Animal Health Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Phibro Animal Health Corporation have in circulation?
The max supply of Phibro Animal Health Corporation shares is 41.25M.
What is Phibro Animal Health Corporation Price to Earnings Ratio (PE Ratio)?
Phibro Animal Health Corporation PE Ratio is 35.29411700 now.
What was Phibro Animal Health Corporation earnings per share over the trailing 12 months (TTM)?
Phibro Animal Health Corporation EPS is 0.34 EUR over the trailing 12 months.
Which sector does the Phibro Animal Health Corporation company belong to?
The Phibro Animal Health Corporation sector is Healthcare.